6-32832444-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2

The NM_001290043.2(TAP2):​c.1161G>A​(p.Val387Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0239 in 1,612,722 control chromosomes in the GnomAD database, including 570 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.020 ( 46 hom., cov: 32)
Exomes 𝑓: 0.024 ( 524 hom. )

Consequence

TAP2
NM_001290043.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.65

Publications

8 publications found
Variant links:
Genes affected
TAP2 (HGNC:44): (transporter 2, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014]
TAP2 Gene-Disease associations (from GenCC):
  • MHC class I deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 6-32832444-C-T is Benign according to our data. Variant chr6-32832444-C-T is described in ClinVar as [Benign]. Clinvar id is 466365.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.65 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0204 (3105/152320) while in subpopulation AMR AF = 0.0283 (433/15302). AF 95% confidence interval is 0.0261. There are 46 homozygotes in GnomAd4. There are 1378 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 46 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAP2NM_001290043.2 linkc.1161G>A p.Val387Val synonymous_variant Exon 7 of 12 ENST00000374897.4 NP_001276972.1 Q03519-1Q5JNW1
TAP2NM_018833.3 linkc.1161G>A p.Val387Val synonymous_variant Exon 7 of 12 NP_061313.2 Q03519-2Q9UP03

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAP2ENST00000374897.4 linkc.1161G>A p.Val387Val synonymous_variant Exon 7 of 12 1 NM_001290043.2 ENSP00000364032.3 Q03519-1
ENSG00000250264ENST00000452392.2 linkc.1161G>A p.Val387Val synonymous_variant Exon 7 of 15 2 ENSP00000391806.2 E7ENX8

Frequencies

GnomAD3 genomes
AF:
0.0204
AC:
3104
AN:
152202
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0232
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0283
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0234
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.0145
AC:
3561
AN:
245660
AF XY:
0.0139
show subpopulations
Gnomad AFR exome
AF:
0.0207
Gnomad AMR exome
AF:
0.0182
Gnomad ASJ exome
AF:
0.00673
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00315
Gnomad NFE exome
AF:
0.0215
Gnomad OTH exome
AF:
0.0192
GnomAD4 exome
AF:
0.0242
AC:
35398
AN:
1460402
Hom.:
524
Cov.:
32
AF XY:
0.0230
AC XY:
16727
AN XY:
726462
show subpopulations
African (AFR)
AF:
0.0209
AC:
701
AN:
33472
American (AMR)
AF:
0.0197
AC:
880
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.00750
AC:
196
AN:
26130
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86194
European-Finnish (FIN)
AF:
0.00354
AC:
185
AN:
52312
Middle Eastern (MID)
AF:
0.00452
AC:
26
AN:
5754
European-Non Finnish (NFE)
AF:
0.0288
AC:
32071
AN:
1111816
Other (OTH)
AF:
0.0220
AC:
1329
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2075
4149
6224
8298
10373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1298
2596
3894
5192
6490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0204
AC:
3105
AN:
152320
Hom.:
46
Cov.:
32
AF XY:
0.0185
AC XY:
1378
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0232
AC:
962
AN:
41552
American (AMR)
AF:
0.0283
AC:
433
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0234
AC:
1591
AN:
68028
Other (OTH)
AF:
0.0298
AC:
63
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
145
290
435
580
725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0192
Hom.:
42
Bravo
AF:
0.0233
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0234
EpiControl
AF:
0.0234

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

MHC class I deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TAP2-related disorder Benign:1
May 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
5.9
DANN
Benign
0.72
PhyloP100
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2856992; hg19: chr6-32800221; API